Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 3043-3049, July 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nerurkar, P. V.
Right arrow Articles by Levy, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nerurkar, P. V.
Right arrow Articles by Levy, G. N.

DNA Adducts of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) in Colon, Bladder, and Kidney of Congenic Mice Differing in Ah Responsiveness and N-Acetyltransferase Genotype

Pratibha V. Nerurkar, Herman A. J. Schut, Lucy M. Anderson1, Charles W. Riggs, Elizabeth G. Snyderwine, Snorri S. Thorgeirsson, Wendell W. Weber, Jerry M. Rice and Gerald N. Levy

Laboratory of Comparative Carcinogenesis, National Cancer Institute [P. V. N., L. M. A., J. M. R.], and Data Management Services, Inc. [C. W. R.], Frederick Cancer Research and Development Center, Frederick, Maryland 21702; Department of Pathology, Medical College of Ohio, Toledo, Ohio 43699 [H. A. J. S.]; Laboratory of Experimental Carcinogensis, National Cancer Isntitute, Bethesda, Maryland 20892 [E. G. S., S. S. T.]; and Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109 [W. W. W., G. N. L.]

Heterocyclic amines, suspected as cancer initiators, require metabolic activation to exert genotoxicity. The food carcinogen 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) undergoes activation via N-hydroxylation by cytochrome P450 1A2, followed by O-esterification by N-acetyltransferase. We examined the effects of the Ah locus and acetylator polymorphisms (implicated in human colon and bladder cancer risk) on levels of 32P-postlabeled IQ-DNA adducts in C57BL/6 mice congenic for slow acetylation and/or Ah nonresponsiveness. Some were pretreated with ß-naphthoflavone (ßNF), an inducer of cytochromes P450 1A. Guanine adducts were detected in all organs, the predominant one corresponding to N2-(deoxyguanosin-8-yl)-IQ. In the kidney, ßNF pretreatment reduced total adducts by 50% in Ah-responsive animals (P = 0.021); the Ah or acetylator phenotype did not otherwise affect total adducts. In the colon of Ah-nonresponsive animals, rapid acetylators had 3-fold more adducts than slow acetylators (P = 0.0001, vehicle-pretreated; P = 0.0031, ßNF-pretreated). In Ah-responsive mice of either acetylator phenotype, ßNF pretreatment reduced total adducts in the colon by 70% (P = 0.0003). A significant interaction of phenotypes occurred in the bladder; ßNF-pretreatment caused a 2.5-fold increase in adducts but only in the Ah-responsive, rapid acetylator mice. In sum, these polymorphisms influenced the level of IQ-DNA adducts in the kidney, urinary bladder, and colon in complex ways.

1 To whom requests for reprints should be addressed, at Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Building 538, Room 205E, Frederick, MD 21702-1201.

Received 1/23/95. Accepted 5/16/95.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
V. M. Lakshmi, F. F. Hsu, and T. V. Zenser
N-Demethylation Is a Major Route of 2-Amino-3-Methylimidazo[4,5-f]quinoline Metabolism in Mouse
Drug Metab. Dispos., June 1, 2008; 36(6): 1143 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Shin, M. J. Shrubsole, J. M. Rice, Q. Cai, M. A. Doll, J. Long, W. E. Smalley, Y. Shyr, R. Sinha, R. M. Ness, et al.
Meat Intake, Heterocyclic Amine Exposure, and Metabolizing Enzyme Polymorphisms in Relation to Colorectal Polyp Risk
Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Cascorbi, I. Roots, and J. Brockmoller
Association of NAT1 and NAT2 Polymorphisms to Urinary Bladder Cancer: Significantly Reduced Risk in Subjects with NAT1*10
Cancer Res., July 1, 2001; 61(13): 5051 - 5056.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. A.J. Schut and E. G. Snyderwine
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Carcinogenesis, March 1, 1999; 20(3): 353 - 368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.